Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)

NCT02398058 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Soft Tissue Sarcoma
Bone Tumor

Interventions

DRUG: trabectedin
DRUG: olaparib

Sponsor

Italian Sarcoma Group

Collaborators

[object Object]
[object Object]
[object Object]